Every financial statement,
one clean chart.
Search any US-listed company. Data straight from SEC filings.
MADRIGAL PHARMACEUTICALS, INC. (MDGL), most recent 12 months reported: revenue $1.28B, net loss $325.1M, free cash flow -$190.02M. Latest balance sheet on file: liquid cash $838.75M, total debt $340.79M, net cash $497.96M. From SEC filings. More on MADRIGAL PHARMACEUTICALS, INC.: Revenue · Profitability · Cash flow · Debt Others in Pharmaceutical Preparations: SAREPTA THERAPEUTICS, INC. · Alkermes plc. · Phibro Animal Health Corporation · Indivior Pharmaceuticals, Inc. · ACADIA PHARMACEUTICALS INC. · INSMED INC · PRESTIGE CONSUMER HEALTHCARE INC. · PTC Therapeutics, Inc.
Filter every US company by the numbers — net cash, margins, ROIC, growth. Looking for one company? The search box above is free.
Follow a company and we'll email you when it files a quarterly or annual report with the SEC. Free follows 3 companies; Pro follows up to 500, and sorts and filters them.